| SVOBODA, Marek, Jiří ŠÁNA, Martina RÉDOVÁ, Jiří NAVRÁTIL, Markéta PALÁCOVÁ, Pavel FABIAN, Ondřej SLABÝ and Rostislav VYZULA. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagnostic Pathology. 2012, vol. 7, March, p. 31-35. ISSN 1746-1596. Available from: https://dx.doi.org/10.1186/1746-1596-7-31. |
Other formats:
BibTeX
LaTeX
RIS
@article{984200,
author = {Svoboda, Marek and Šána, Jiří and Rédová, Martina and Navrátil, Jiří and Palácová, Markéta and Fabian, Pavel and Slabý, Ondřej and Vyzula, Rostislav},
article_number = {March},
doi = {http://dx.doi.org/10.1186/1746-1596-7-31},
keywords = {triple-negative breast cancer; miR-34a; miR-34b; miR-34c; prognosis},
language = {eng},
issn = {1746-1596},
journal = {Diagnostic Pathology},
title = {MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.},
url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349474/?tool=pubmed},
volume = {7},
year = {2012}
}
TY - JOUR
ID - 984200
AU - Svoboda, Marek - Šána, Jiří - Rédová, Martina - Navrátil, Jiří - Palácová, Markéta - Fabian, Pavel - Slabý, Ondřej - Vyzula, Rostislav
PY - 2012
TI - MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
JF - Diagnostic Pathology
VL - 7
IS - March
SP - 31-35
EP - 31-35
SN - 17461596
KW - triple-negative breast cancer
KW - miR-34a
KW - miR-34b
KW - miR-34c
KW - prognosis
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349474/?tool=pubmed
N2 - Breast cancer is the most common malignancy with the highest incidence rates among women worldwide. Triple-negative breast cancer (TNBC) represents the major phenotype of basal-like molecular subtype of breast cancer, characterized by higher incidence in young women and a very poor prognosis. MicroRNAs (miRNAs) are small non-coding RNAs playing significant role in the pathogenesis of many cancers including breast cancer. Therefore, miRNAs are also potential prognostic and/or predictive biomarkers in triple-negative breast cancer patients.
ER -
SVOBODA, Marek, Jiří ŠÁNA, Martina RÉDOVÁ, Jiří NAVRÁTIL, Markéta PALÁCOVÁ, Pavel FABIAN, Ondřej SLABÝ and Rostislav VYZULA. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. \textit{Diagnostic Pathology}. 2012, vol.~7, March, p.~31-35. ISSN~1746-1596. Available from: https://dx.doi.org/10.1186/1746-1596-7-31.
|
